Translation elongation factor 1A2 (eEF1A2) is encoded by one of four closely related eef1a genes and is dispensable for survival in zebrafish by Idigo, Nwamaka et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Translation elongation factor 1A2 (eEF1A2) is encoded by one of
four closely related eef1a genes and is dispensable for survival
in zebrafish
Citation for published version:
Idigo, N, Soares, D & Abbott, C 2020, 'Translation elongation factor 1A2 (eEF1A2) is encoded by one of
four closely related eef1a genes and is dispensable for survival in zebrafish', Bioscience reports.
https://doi.org/10.1042/BSR20194191
Digital Object Identifier (DOI):
10.1042/BSR20194191
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Bioscience reports
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 11. May. 2020
Bioscience Reports (2020) 40 BSR20194191
https://doi.org/10.1042/BSR20194191
*Present address: ACS
International Ltd., Begbroke
House, Wallbrook Court, North
Hinksey Lane, Oxford OX2 0QS,
United Kingdom
Received: 10 December 2019
Revised: 16 January 2020
Accepted: 17 January 2020
Accepted Manuscript online:
17 January 2020
Version of Record published:
31 January 2020
Research Article
Translation elongation factor 1A2 is encoded by one
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Zebrafish are valuable model organisms for the study of human single-gene disorders: they
are genetically manipulable, their development is well understood, and mutant lines with
measurable, disease-appropriate phenotypic abnormalities can be used for high through-
put drug screening approaches. However, gene duplication events in zebrafish can result in
redundancy of gene function, masking loss-of-function phenotypes and thus confounding
this approach to disease modelling. Furthermore, recent studies have yielded contrasting
results depending on whether specific genes are targeted using genome editing to make
mutant lines, or whether morpholinos are used (morphants). De novo missense mutations
in the human gene EEF1A2, encoding a tissue-specific translation elongation factor, cause
severe neurodevelopmental disorders; there is a real need for a model system to study these
disorders and we wanted to explore the possibility of a zebrafish model. We identified four
eef1a genes and examined their developmental and tissue-specific expression patterns:
eef1a1l1 is first to be expressed while eef1a2 is only detected later during development. We
then determined the effects of introducing null mutations into translation elongation factor
1A2 (eEF1A2) in zebrafish using CRISPR/Cas9 gene editing, in order to compare the results
with previously described morphants, and with severe neurodegenerative lethal phenotype
of eEF1A2-null mice. In contrast with both earlier analyses in zebrafish using morpholinos
and with the mouse eEF1A2-null mice, disruption of the eef1a2 gene in zebrafish is com-
patible with normal lifespan. The resulting lines, however, may provide a valuable platform
for studying the effects of expression of mutant human eEF1A2 mRNA.
Introduction
Zebrafish represent a valuable model system for a range of human single gene disorders because they are
genetically manipulable and their development is well understood. Importantly, if mutant zebrafish lar-
vae have detectable phenotypes they can be used for high throughput small molecule library screening
for the discovery of new therapeutically active molecules. However, redundancy of gene function as a re-
sult of gene duplication can confound this approach, and recent studies have yielded contrasting results
that depend on whether specific genes are targeted using genome editing approaches like CRISPR/Cas9,
or whether morpholinos are used [1–3]. One recently discovered human single gene disorder is EEF1A2
related epilepsy, for which model systems are badly needed. In the present study we sought to catalogue
zebrafish eef1a genes, analyse their expression, and determine the effects of ablating expression of trans-
lation elongation factor 1A2 (eEF1A2) in zebrafish.
Translation elongation factor eEF1A, in its active GTP-bound form, is responsible for the delivery of
aminoacylated-tRNAs to the acceptor site of the ribosome during the elongation step of protein synthesis.
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The elongation factor eEF1A is a member of the G protein family and is typically encoded by more than one gene,
often located on distinct chromosomes in different eukaryotic species. Two sequence-redundant eEF1A genes TEF1
and TEF2 are present in the yeast Saccharomyces cerevisiae [4,5]. In Drosophila melanogaster, two genes, F1 and
F2, have been described (Hovemann et al. [6]) while four and five eEF1A genes have been reported inXenopus laevis
and Solea senegalensis, respectively [7–9].
In mammals, although numerous pseudogenes exist, only two active genes, EEF1A1 and EEF1A2, encoding dis-
tinct but highly similar proteins (eEF1A1 and eEF1A2) have been reported [10–13]. These genes exhibit a devel-
opmental and tissue-specific pattern of expression: eEF1A1 is widely expressed during development but is then
down-regulated in neurons, skeletal and cardiac muscle postnatally and replaced in these tissues with eEF1A2, which
is concomitantly up-regulated [11,13–15].
In non-mammalian vertebrates the picture is less clear, but differential gene expression among the eEF1A genes
has been noted for S. senegalensis (Senegalese sole) during larval development [8]. Expression of eEF1A genes in
Xenopus is regulated post-transcriptionally.Newbery et al. [9] showedoverlapping expression of eEF1A1 and eEF1A2
transcripts in the brain, heart and muscle tissues. However, at the protein level they observed a down-regulation of
eEF1A1 in the brain and spinal cord and complete absence in Xenopus muscle. The eEF1A2 orthologue in Xenopus
showed the same expression pattern as that of mammals, with expression restricted to the central nervous system
and muscle tissues. While the importance of this isoform switching remains to be elucidated, it has been suggested
that the isoforms may have additional distinct ‘moonlighting’ or non-canonical roles (reviewed in [16,17]) that are
required for the different cell types [18].
There are several lines of evidence implicating eEF1A2 in neurological disorders. A spontaneous deletion spanning
15.8 kilobases involving the promoter and first exon of Eef1a2 is responsible for the wasted (wst) phenotype in mice
[15,19].Mice homozygous for thismutation initially develop normally but then developmuscle wasting and neuronal
degeneration from 21 days of age, the stage at which Eef1a1 is down-regulated to undetectable levels in these tissues
[15,20]. The severity of the wasted phenotype progresses rapidly, leading to paralysis and death of the mouse by
28 days postnatally. On the other hand, heterozygous mice are healthy and do not show any muscular or neuronal
abnormalities [21].
More recently, many heterozygous de novo missense mutations have been identified in individuals with neurode-
velopmental disorders encompassing epilepsy, intellectual disability and autism [22–27]. Subsequently, Cao et al. [28]
reported a homozygousmissense EEF1A2mutation (P333L) in siblings that resulted in intractable seizures and death
before the age of 5 from dilated cardiomyopathy. The severity of these disorders makes it important that model sys-
tems are developed for testing therapeutic strategies.
Zebrafish (Danio rerio) could provide a valuablemodel system for neurological disorders resulting frommutations
in eEF1A2, but relatively little is known about eEF1A in zebrafish. In fact, it was first reported that only one eEF1A
gene, which appeared to be developmentally regulated, was present in the zebrafish genome [29]. In addition, a gene
identified as eef1a has been shown to be an essential gene required for early embryonic development in zebrafish
[30]. More recently, Cao et al. [28] reported that knockdown of eef1a2 with morpholinos resulted in small head,
cardiac failure and skeletal muscle weakness at 2 days post-fertilisation (dpf). Together these results would suggest
that mutation of any eef1a gene in zebrafish is lethal.
The complete sequence of the zebrafish genome is now available. Using this resource, we have identified and char-
acterised the expression pattern of four eef1a genes; eef1a1l1, eef1a1a, eef1a1b and eef1a2, during development and
in different adult tissues.We show eef1a1l1 to be the embryonic formbeing the first to be expressedwhile eef1a2 is the
‘adult’ form, detected later on during development. We went on to generate eef1a2 null zebrafish using CRISPR-Cas9
gene editing and show in contrast with earlier analysis based on morpholinos, that disruption of the eef1a2 gene is
compatible with normal function in zebrafish.
Materials and methods
Zebrafish husbandry and embryos and adult tissues collection
Zebrafish of the AB strain were used for all experiments. They were maintained in the MRC Human Genetics Unit
(HGU) zebrafish facility at the University of Edinburgh according to standard procedures (Westerfield [31]). Em-
bryos were raised at 28.5◦C in Petri dishes containing E3 embryo medium and staged according to Kimmel et al.
[32]. For RNA isolation, embryos and larvae were collected, rinsed with water, snap-frozen in dry ice and stored at
−70◦C until needed. Adult zebrafish were killed by immersing in excess Tricaine. Tissues were quickly dissected,
placed in RNAlater® solution (Invitrogen) and stored at −70◦C until RNA preparation. Zebrafish were maintained
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in accordance with U.K. Home Office Regulations, U.K. Animals (Scientific Procedures) Act 1986, under project li-
cense 60/4418. All experiments were approved by the Home Office and AWERB (University of Edinburgh Ethics
Committee).
Bioinformatics
Nucleotide and protein sequences of the eEF1A genes for zebrafish and other species were obtained from the Ensembl
genome browser (https://www.ensembl.org/index.html). Multiple alignments of protein sequences were carried out
using Clustal Omega (https://www.ebi.ac.uk/Tools/msa/clustalo/) and BoxShade v3.21 (https://embnet.vital-it.ch/
software/BOX form.html). A phylogenetic tree was constructed with the MEGA version 6 software [33] and anal-
ysed using themaximum likelihoodmethod based on the Poisson correctionmodel [34]. The tree with the highest log
likelihood (−2809.8575) is shown. The percentage of trees in which the associated taxa clustered together is shown
next to the branches. Initial tree(s) for the heuristic search were obtained automatically by applying Neighbour-Join
and BioNJ algorithms to a matrix of pairwise distances estimated using a JTTmodel, and then selecting the topology
with superior log likelihood value. The tree is drawn to scale, with branch lengths measured in the number of sub-
stitutions per site. The reliability of each branch was assessed using 1000 bootstrap replicates and reliable assignment
values indicated. The analysis involved 24 amino acid sequences. All positions with less than 95% site coverage were
eliminated. That is, fewer than 5% alignment gaps, missing data and ambiguous amino acids were allowed at any
position. There were a total of 462 positions in the final dataset.
RNA extraction and RT-PCR analysis
Total RNA from adult fish tissues and approximately 50 embryos/larvae per developmental stage were isolated using
TRIzol® (Invitrogen) and cleaned up with the RNeasy Mini Kit (Qiagen) with on-column DNase treatment using
RNase-free DNase (Qiagen) according to the manufacturer’s instructions. RNA concentration and integrity were
analysed using the Agilent 2100 Bioanalyzer. Full-length cDNA was then synthesised with a mix of random and
oligo (dT) using the AffinityScript Multiple Temperature cDNA Synthesis Kit (Agilent Genomics) according to the
manufacturer’s protocol. RT-PCR was carried out using primers for the zebrafish eEF1A genes with the Phusion
High-Fidelity PCR master mix. Zebrafish actb2 was amplified as an internal control. Primer sequences are shown
in Table 1. Primers for actb2 were also used to assess cDNA for genomic DNA contamination, with an additional
amplicon of 684 bp seen if genomic DNA was present. Products were run on 2% agarose gel.
Quantitative real-time PCR
RNA and cDNA preparation from brain, muscle and liver tissues of adult fish were performed as described above.
All quantitative real-time PCR (qRT-PCR) experiments were performed on diluted cDNA (1:5 in nuclease-free wa-
ter) using the Brilliant II SYBR Green qPCR Master Mix (Agilent Technologies) and the 7900HT Real-Time PCR
system (Applied Biosystems). A total of 4 μl of each cDNA sample was added to 6 μl of qRT-PCR mix following the
manufacturer’s protocol. Reactions were performed under the following conditions: 95◦C for 10 min, 50 cycles of
95◦C for 30 s and 60◦C for 1 min. For normalisation of gene expression, three reference genes were used: ATPsynth,
NADH and 16S (selected using the geNorm kit from PrimerDesign Ltd, U.K.). Prevalidated primers (PrimerDesign
Ltd, U.K.) were used for these experiments unless otherwise stated. Primer sequences shown in Table 1 are copy-
righted by PrimerDesign Ltd, U.K. Sequences for the reference genes are however not disclosed by the company. To
assess efficiencies, a standard curve was generated from seven four-fold serial dilutions of pooled cDNA from whole
adult fish (1:4, 1:16, 1:64, 1:256, 1:1024, 1:4096 and 1:16384) for each primer pair (Table 2). Gene expression was
quantified using the standard curve method. To compare the amount of each zebrafish eef1a transcript, the Pfaffl
method [35] was used to calculate the gene expression ratio of each target mRNA relative to the geometric average of
the reference genes for each tissue. Results are based on the analysis of three biological replicates, each with triplicate
technical replicates (a no-template control was included for each gene). Significance testing was performed using the
Mann–Whitney test or one-way ANOVA with Tuke’s multiple comparison tests where appropriate.
Expression vector construction and HEK293T cell line transfection
Total RNA and full-length cDNAwere prepared fromwhole adult fish as described above. The zebrafish eef1a cDNAs
were cloned into the destination vector, pcDNA6.2C-EmGFP for expression in mammalian cell lines using Gateway
Cloning technology (Invitrogen) following themanufacturer’s instructions. The zebrafish eef1a genes were expressed
together with a GFP tag in order to be able to discriminate between the exogenously expressed eEF1As and endoge-
nous eEF1A1 of HEK293T cells. Each of the constructs were transfected into HEK293T cells using the TurboFect
© 2020 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
License 4.0 (CC BY).
3
D
ow
nloaded from
 https://portlandpress.com
/bioscirep/article-pdf/40/1/BSR
20194191/866949/bsr-2019-4191.pdf by U
niversity of Edinburgh user on 11 February 2020
Bioscience Reports (2020) 40 BSR20194191
https://doi.org/10.1042/BSR20194191
Table 1 Sequences of primers
Expression analysis of eef1a during development and adult tissues
Grey highlight- indicates primer sequences are copyrighted by Primerdesign Ltd.
eef1a1l1 RT-PCR F ACCTACCCTCCTCTTGGTCG
eef1a1l1 RT-PCR R GGAACGGTGTGATTGAGGGA
eef1a1a RT-PCR F TCCTCCTCTGGGTCGTTTTG
eef1a1a RT-PCR R GTAACCTTTCCGCTTGTCGC
eef1a1b RT-PCR F TCCTCTTGGTCGTTTTGCAGT
eef1a1b RT-PCR R TGTGGCTGACCCAAGTGTTT
1eef1a2 RT-PCR F TACTGTTCTCTCTTGCCGCC
1eef1a2 RT-PCR R TTTTCCCATCTCAGCTGCCT
actb2 F GATCAAGATCATTGCCCCACC
actb2 R GAGTCGGCGTGAAGTGGTAA
Expression analyses in Del2 and Ins4 eef1a2 mutant lines1
eef1a2 F (Primerdesign) AGGCGGATTGTGCTGTCTT
eef1a2 R (Primerdesign) GGCGTGTTCCCTTGTTTGG
eef1a1l1 F (Primerdesign) GAGGAAATCACCAAGGAAGTCA
eef1a1l1 R (Primerdesign) GTTGTCACCGTGCCATCC
eef1a1a F (Primerdesign) GATTGTGCTGTGCTGATTGTG
eef1a1a R (Primerdesign) GTAAGCCAGAAGAGCGTGTT
eef1a1b F (Primerdesign) CTTGCTGGCGTACACTCTC
eef1a1b R (Primerdesign) GACTTCCTTCACAATCTCCTCAT
3′ eef1a2 RT-PCR F AGTATCCTCCACTGGGACGC
3′ eef1a2 RT-PCR R AGCTGATTTGGTCACTCTCCC
1eef1a2 RT-PCR F and R was also used in the expression analyses in Del2 and Ins4 eef1a2 mutant lines experiment.
Table 2 Slope, intercept and correlation coefficient (R2) output from SDS software to estimate efficiency of primers used for
qPCR analyses
Primer Slope y-intercept Correl. Coeff. (R2)
eef1a1l1 −3.296 11.766 0.997
eef1a1a −3.223 19.571 0.997
eef1a1b −3.283 20.197 0.996
eef1a2P −3.294 21.767 0.994
eef1a2S −3.495 20.357 0.981
3′ eef1a2 −3.208 22.445 0.992
ATPsynth −3.237 14.832 0.999
NADH −3.227 16.500 0.996
16S −3.018 10.194 0.991
Transfection reagent (Thermo Fisher Scientific) according to the manufacturer’s protocol, with an empty vector con-
trol included. Twenty-four hours before transfection, 2.4 × 104 cells were seeded per well of a six-well cell culture
plate containing 4 ml of DMEM (Gibco) with 10% fetal bovine serum (FBS) growth medium. For each transfection
reaction, 4 μg of plasmid DNA was diluted in 400 μl of serum-free DMEM (Gibco). The transfection reagent was
briefly vortexed, then 6 μl was added to the diluted DNA. The reaction was mixed gently and incubated for 15 min at
room temperature. The transfection mix (400 μl) was added to each well and mixed by rocking the plate gently. Cells
were incubated at 37◦C in a CO2 incubator for 24 h, after which they were analysed for transgene expression.
Protein analysis
Protein lysates from adult zebrafish tissues and transfected HEK293T cells were prepared using RIPA lysing buffer
with EDTA-free protease inhibitor (Roche). Concentration of protein lysates was determined using either the Pierce
BCA protein assay kit (Pierce) or the DC Protein Assay (Bio-Rad) following themanufacturers’ instructions.Western
blotting was carried out using near-infrared detection method by LI-COR as previously described in [36]. Protein
detection was also performed using the chemiluminescence method. In this case, after quantification of total pro-
tein using Sypro Ruby Blot Stain (Invitrogen) was analysed, blots were blocked at room temperature for 1 h in 5%
4 © 2020 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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dried skimmed milk in TBS-0.1% Tween 20 (TBST). Membranes were incubated with primary antibody in blocking
buffer overnight at 4◦C, washed three times in TBST for 5 min and then incubated with the appropriate horseradish
peroxidase-conjugated secondary antibody diluted in blocking buffer for 1 h at room temperature. Finally, mem-
branes were washed three times for 5 min each in TBST and protein detected using Clarity western ECL substrate
(Bio-Rad) according to the manufacturer’s instructions.
CRISPR/Cas9 experiment
Single guide RNA (sgRNA) targeting the zebrafish eef1a2 gene was designed using the online tool CHOPCHOP
(http://chopchop.cbu.uib.no/) and the oligonucleotides TAGGATAAGTTGAAGGCTGAGA andAAACTCTCAGC-
CTTCAACTTAT purchased from Integrated DNA Technologies (IDT) with a 5′ phosphate modification to increase
ligation efficiency. The sgRNA construct was made by inserting annealed pairs of oligonucleotides into Bsal (New
England Biolabs) digested pDR274 (Addgene #42250) backbone. The sgRNA plasmid was used as a template to am-
plify gRNA sequences, which were then transcribed using the AmbionMAXIscript T7 kit (Thermo Fisher Scientific).
Cas9 mRNA was synthesised by transcribing NotI-digested pCS2-nCas9n (Addgene #47929) using the SP6 mMES-
SAGE mMACHINE kit (Thermo Fisher Scientific) to generate capped mRNA. Purification of synthesised mRNA
was performed using SigmaSpin sequencing reaction clean-up kit (Sigma–Aldrich) according to the manufacturer’s
instructions.
Microinjection
Injection mixture containing 300 ng/μl Cas9 mRNA and 92 ng/μl sgRNA was prepared and injected into the cell
of one-cell-stage zebrafish embryos. At 2 dpf, genomic DNA was extracted from a pool of five to ten microinjected
healthy embryos and the target region was amplified using the primer set 5′ CACCTTTATTTTTGCGTGAACA and
5′ TCAAAAACATGATCACTGGGAC. In order to assess the mutagenic efficiency of the gRNA, PCR products were
TOPO cloned using the TOPO-TA cloning kit (Invitrogen) and individual clones were sequenced. Founder fish (3
months)were screened by amplifying target region using genomicDNAextracted from tail fin clippings and analysing
the amplicons on the Agilent 2100 Bioanalyser.
Establishing stable mutant lines
Putative founders were outcrossed with wild-type AB fish. To determine whether the Cas9-induced mutations were
heritable, genomic DNA from ten individual embryos were assessed for indels, while the others were raised to adult-
hood. Mutant alleles were identified in F1 fish by Sanger sequencing and fish with identical mutations were mated.
Confirmation of the sequence of the alleles was achieved with the homozygous F2 fish using Phusion High-Fidelity
DNA Polymerase (NEB) and Sanger sequencing.
Histology
Adult zebrafish fromboth eef1a2mutant lines and age-matchedwild-type controls were fixed in 10%neutral buffered
formalin (Sigma–Aldrich). Spinal cord sections were cut at a thickness of 3 μm. Paraffin-embedded spinal cord sec-
tions were dewaxed with xylene and rehydrated through decreasing series of ethanol. Antigen retrieval was carried
out using Proteinase K for 10 min at room temperature and slides were then treated with 3% hydrogen peroxide to
block endogenous peroxidase. Sections were blocked with goat serum (1:5 in PBS) for 10 min. They were incubated
overnight with anti-glial fibrillary acidic protein (GFAP) rabbit antibody (Dako) diluted at 1:500 in PBS, washed twice
with PBS for 5 min and then incubated with anti-rabbit biotinylated antibody (Dako) at a concentration of 1:500 in
PBS for 30min at room temperature. Sections were then treated with Strept ABC reagent (Vector Laboratories) for 30
min and with Diaminobenzidine (DAB; Abcam) for 10 min. Sections were counterstained in Haematoxylin solution
(Shandon), dehydrated and finally mounted in DPX (VWR).
Results
Characterisation of the zebrafish eef1a genes
Bioinformatics analysis of eef1a genes in the zebrafish
To determine the full complement of eef1a genes in zebrafish, we identified four eef1a genes using Ensembl, namely,
eef1a1l1, eef1a1a, eef1a1b and eef1a2 located on chromosome 19, 13, 1 and 23, respectively. Each contained eight
exons, seven introns and an open reading frame encoding distinct proteins of 462 (Eef1a1l1, Eef1a1a and Eef1a1b)
or 463 (Eef1a2) amino acids. They also had similar exon–intron organisation with the 5′UTRs extending into exon 2
and the 3′UTR starting in exon 8.While coding exons were of a consistent size, some introns of eef1a1a, eef1a1b and
© 2020 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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eef1a2 are greatly expanded compared with the compact introns of eef1a1l1 (Figure 1A). The zebrafish eef1a genes
shared high sequence similarity at the nucleotide level within the coding region and also at the amino acid level, with
eef1a1a and eef1a1b being particularly closely related (Figure 1B).
The phylogenetic relationships of the four zebrafish Eef1a protein sequences and those from other vertebrate
species were analysed using the maximum likelihood method (Figure 1C). The phylogenetic tree obtained from this
analysis showed that both Eef1a1a and Eef1a1b fall into the eEF1A1 clade while the zebrafish Eef1a2 segregated with
eEF1A2 from the other vertebrates. In contrast, Eef1a1l1 did not cluster with any of the well-supported clades but
appears to possess sequence features similar to both eEF1A1 and eEF1A2.
Alignment of the protein sequences of eEF1A protein sequences from zebrafish, mouse and human using Clustal
omega (Figure 2) also showed Eef1a1a and Eef1a1b to have higher sequence identity of∼95%withmouse and human
eEF1A1 than those obtained for Eef1a1l1 and Eef1a2. The zebrafish Eef1a2 showed higher sequence identity of∼94%
with mouse and human eEF1A2 than those obtained for Eef1a1l1, Eef1a1a and Eef1a1b. On the other hand, Eef1a1l1
had similar sequence identity to the eEF1A orthologues in mouse and human, with∼92% for eEF1A1 and∼90% for
eEF1A2 in both species.
Expression of eef1a genes during development and adult tissue
The expression of each zebrafish eef1a gene was analysed at each of 12 different developmental stages; 1-, 2-, 4-,
8-, 16-, 256-, high, 50%-epiboly, 90%-epiboly, 24 h post-fertilisation (hpf), 48 and 72 hpf stages (Figure 3A). Only
eef1a1l1 transcripts were detected at all the stages examined. Expression of eef1a1a and eef1a1b transcripts were
detected at the 24, 48 and 72 hpf developmental stages. The zebrafish eef1a2 gene was the last to be expressed, being
detected only at 48 and 72 hpf (Figure 3B).
We used RT-PCR to examine the expression of the zebrafish eef1a genes in adult tissues using total RNA extracted
from brain, muscle, spleen, testis, intestine, liver and ovary (Figure 3C). Three of the zebrafish eef1a genes, eef1a1l1,
eef1a1a and eef1a1b were readily detected in all the tissues examined. Expression of zebrafish eef1a2 was detected in
brain, muscle, spleen, testis and ovary tissues but was only just detectable in the intestine. No eef1a2 expression was
seen in the liver. Using qPCR, we then analysed the level of expression for each eef1a gene in the brain, muscle and
liver (Figure 3D). The expression level of eef1a1l1 was significantly higher in liver than in brain (P<0.01) andmuscle
(P<0.05). Similar expressionwere seen for eef1a1a, eef1a1b and eef1a2with brain showing the highest level, followed
by muscle and liver. The relative amount of the four eef1a transcripts in these tissues were calculated (Figure 3E). In
general, themost abundant transcript was that of eef1a1l1with approximately 7980, 7830 and 240-fold higher overall
expression ratios than eef1a1a, eef1a1b and eef1a2, respectively.While the relative amount of all the eef1a transcripts
was similar in brain, eef1a1l1 showed the highest value in muscle (1040, 1280 and 490-fold higher than eef1a1a,
eef1a1b and eef1a2, respectively) and liver (22900- and 22200-fold higher in eef1a1a and eef1a1b, respectively)
tissues. The relative amount of eef1a2 transcripts in muscle was approximately two- and three-fold higher than that
of eef1a1a and eef1a1b, respectively, both of which showed similar amounts in all three tissues examined.
Validation of commercially available eEF1A2 antibody
To investigate whether the eef1amRNAs detected are translated into stable proteins, we needed to identify a suitable
antibody. Three commercially available antibodies against Eef1a2 were tested on protein lysates from adult zebrafish
brain, liver and muscle tissues. The Genetex and Proteintech anti-eEF1A2 antibodies detected a band in liver (data
not shown) in spite of the absence of Eef1a2 at the mRNA level (Figure 3C,D). However, an antibody from Abcam
detected a band only in lysates fromadult zebrafish brain andnot in liver, consistentwith our qRT-PCRdata for Eef1a2
(Figure 3F). This antibody was then used to test a range of other adult tissues: muscle, spinal cord, intestine, ovary
and heart. Interestingly, expression was only detected in spinal cord and not muscle, in contrast with our RT-PCR
results (data not shown).
Since the interpretation of results using this antibody could be complicated by the presence of other Eef1a par-
alogues, we carried out an antibody validation test. GFP-tagged constructs were made for each of the four zebrafish
eef1a genes, transfected intoHEK293T cells and lysates analysed with the eEF1A2-Abcam antibody. A band of the ex-
pected size was observed in lanes containing lysates isolated from cells transfected with GFP-tagged Eef1a1a, Eef1a1b
and Eef1a2 (Figure 3G), suggesting that this antibody cross-reacts with other Eef1a paralogues.
CRISPR/Cas9 generated Eef1a2-null zebrafish survive to adulthood
We next sought to investigate the effect of loss of Eef1a2 in zebrafish using the CRISPR/Cas9 system. We wanted to
establish whether zebrafish, like mice, undergo fatal neurodegeneration in response to the loss of eEF1A2 after de-
velopmental down-regulation of eEF1A1; consistent with the lethal phenotype arising from the use of morpholinos
6 © 2020 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
License 4.0 (CC BY).
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Figure 1. Four eef1a genes identified in the zebrafish genome
(A) Schematic representation of the exon–intron organisation of eef1a1l1 (red), eef1a1a (black), eef1a1b (blue) and eef1a2 (yellow)
structures obtained from the Ensembl database. Length (in base pairs) of exons and introns, which are not drawn to scale, are
indicated above and below respectively. (B) Percentage identity matrix for zebrafish Eef1as at the nucleotide and amino acid
sequence level (in brackets) calculated using Clustal Omega. (C) Phylogenetic relationship among the zebrafish Eef1as and other
vertebrate eEF1As using the maximum likelihood method.
© 2020 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
License 4.0 (CC BY).
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Figure 2. Multiple amino acid sequence alignment of eEF1A orthologues from zebrafish, human and mouse
The human eEF1A: heEF1A1 and heEF1A2, mouse eEF1A: meEF1A1 and meEF1A2. Identical and similar amino acid residues are
indicated by black and grey backgrounds. Red asterisks (*) indicate some of the residues that are mutated in human eEF1A2, which
are completely conserved in the four zebrafish eEF1A isoforms [22–27].
8 © 2020 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
License 4.0 (CC BY).
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Figure 3. Expression analysis of the zebrafish eef1a genes
(A) Expression of eef1a1l1 in different early embryonic stages detected by RT-PCR. The other eef1a genes were undetected at these
stages (data not shown). (B) Expression of eef1a genes in 24, 48 and 72 hpf developmental stages using RT-PCR. NTC, no template
control. (C) Expression of eef1a genes in different tissues of adult zebrafish detected by RT-PCR. (D) Expression levels of eef1a
genes in brain, muscle and liver tissues, and (E) comparison of the relative levels of their transcripts in these tissues. Expression
values were normalised to those of ATPsynth, NADH and 16S. Results are means +− SD, n=3. *P<0.05; **P<0.01; ***P<0.0001. For
comparison, data were presented as the gene expression ratio of the target mRNA to the geometric mean of reference genes for
each tissue. (F) Western blot showing Eef1a2 expression in brain, liver and muscle zebrafish tissues using eEF1A2-Abcam antibody
(1:1000). Control is muscle tissue frommouse. (G) Validation of eEF1A2-Abcam antibody (ab82912) specificity using lysates isolated
from individually transfected HEK293T cells with GFP-tagged Eef1a constructs. Abbreviation: Zf, zebrafish.
© 2020 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
License 4.0 (CC BY).
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against eEF1A2 as shown by Cao et al. [28] or whether the presence of three paralogues in zebrafish gives rise to re-
dundancy. A sgRNA targeting the zebrafish eef1a2 gene was designed andmicroinjected, together with Cas9 mRNA,
into one-cell embryos. The gRNA showed a mutagenic activity rate of∼77% and a survival rate of 93% was observed
within the CRISPR-injected embryos. At 2months, adult (F0) injected zebrafish were genotyped using genomic DNA
from tail fin clipping in order to identify potential founders. PCR amplicons containing the target region were anal-
ysed on the Agilent 2100 Bioanalyser which showed several distinct mutations at the target site were present in these
fish (Supplementary Figure S1). In order to establish stable null mutant lines, F1 embryos were obtained from one
of the mosaic putative founders outcrossed with wild-type fish. These embryos were then raised to adulthood and
threemutant alleles, a 27-base pair deletion, a 4-base pair insertion and a 2-base pair deletion, were recovered (Figure
4A). The 4-base pair insertion (hereafter referred to as Ins4) and 2-base pair deletion (hereafter referred to as Del2)
were chosen for further analysis since they were each predicted to give rise to frameshifts resulting in premature stop
codons (Figure 4A). Heterozygous F1 zebrafish carrying the samemutations were then intercrossed and the embryos
raised to adulthood. Interestingly, homozygous Ins4 and Del2 fish survived to adulthood with no obvious phenotypic
differences from their wild-type siblings, and were fertile (Figure 4B).
Expression analysis shows reduced eef1a2 transcripts in Ins4 and Del2 lines
We then went on to investigate the effect of the mutant alleles in each of the Ins4 and Del2 lines. The expression level
of eef1a2 mRNA was assessed using two different set of primers, eef1a2P and 3′eef1a2, for both Ins4 and Del2 lines
and a third primer set, eef1a2S, for Ins4 only (Supplementary Figure S2). The position of the primers in relation to the
target site is shown in Figure 4C. The primer 3′eef1a2 was designed such that it is located towards the extreme 3′ end
of the eef1a2mRNA such that any transcripts downstream of the target site that could lead to translation of a protein
would be detected. A marked decrease in eef1a2 mRNA was seen in both Ins4 and Del2 lines compared with their
wild-type siblings using each of the different sets of primers (Figure 4C). Approximately 81 and 92% reduction in the
levels of eef1a2 expression was seen in Del2 homozygous adult brains when compared with their wild-type siblings
and a reduction in approximately 86 and 95% in brain tissues of homozygous Ins4 adult fish was seen compared
with wild-type. These results suggest that each of the mutant alleles, Ins4 and Del2, lead to decreasedmessenger RNA
levels possibly through nonsense-mediated decay (NMD). Homozygousmutant fish for both lines are thus effectively
eef1a2-null.
Immunohistochemical assessment of Ins4 and Del2 mutants
Complete loss of eEF1A2 in mice has been well characterised and causes motor neuron degeneration of the anterior
horn of the spinal cord and muscle wasting, which is of neurogenic origin [37]. We examined spinal cord sections
from homozygous Ins4 and Del2 adult fish to evaluate them for the presence of gliosis (a reactive response to injuries
such as neurodegeneration in the central nervous system) using immunohistochemistry for GFAP. High levels of
GFAP staining is seen in human cases of motor neuron degeneration and in animal models, including the anterior
horn of the spinal cord of eEF1A2-null mice [38]. However, no increased staining of GFAPwas seen in the spinal cord
sections of homozygousDel2 and Ins4mutants when comparedwith wild-type (Figure 4D). This result, together with
apparently normal histology and normal survival, demonstrates that there is no evidence of neurodegeneration in the
spinal cord of either eef1a2-mutant zebrafish lines.
Other eef1as mRNA remained unchanged in Ins4 and Del2 lines
We next quantified the mRNA level of the other zebrafish eef1a genes in order to address both whether the lack of
phenotype was a result of a compensatory mechanism from the other genes and also whether any off-target effect
involving homologous eef1a genes had occurred. The results obtained showed no significant change in the mRNA
level of any of the other eef1a genes in the brain of adult homozygous Ins4 and Del2 fish (Figure 4E), suggesting
that they were unaffected by the CRISPR/Cas9 targeting of eef1a2, and also that no compensatory mechanism had
occurred, at least at the mRNA level.
Discussion
Four different eEF1A genes, namely eef1a1l1, eef1a1a, eef1a1b and eef1a2 are present in the zebrafish genome and
share high sequence identity both at the nucleotide (75–83%) and amino acid (89–97%) levels. The nucleotide and
amino acid sequences of eef1a1a and eef1a1b are more similar to each other than the other paralogous genes, sug-
gesting that they arose from the additional teleost-specific genome duplication event which took place at the base of
the teleost fish evolutionary lineage [39]. It is clear from our phylogenetic and sequence alignment analyses that the
10 © 2020 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
License 4.0 (CC BY).
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Figure 4. Generation and characterisation of Eef1a2-null zebrafish lines using CRISPR/Cas9
(A) Schematic showing outcross mating of founder (F0) fish and wild-type fish showing recovered F1 sequences (number of F1
fish for each allele are indicated in brackets, target sequences (yellow highlight) and PAM site (purple) with red showing inserted
bases) and the predicted effect of Ins4 and Del2 mutant allele with aberrant residues shown in red (right). (B) No overt difference
in homozygous Del2 (6 months) and homozygous Ins4 (8 months) adult fish from wild-type (6 months) adult fish. (C) The position
of the three different primer sets; eef1a2S (blue triangle), eef1a2P (black triangle) and 3′eef1a2 (red triangle) is illustrated in relation
to the gRNA target site (PAM site sequence in red). Expression levels of eef1a2 in homozygote Del2 (top panel) and homozygote
Ins4 (bottom panel) fish using eef1a2P and 3′eef1a2 primer sets. Results were normalised to ATPsynth, NADH and 16S. (means +−
S.E.M; n=3), *P<0.05. (D) Anti-GFAP antibody stained transverse sections of spinal cords of homozygous Del2 and Ins4 adult fish
showed no sign of neurodegeneration. Negative control of a no primary (No Pri) was included which showed no staining. Scale bar
= 100 μm. (E) Expression levels of eef1a1l1 (left), eef1a1a (middle) and eef1a1b (right) mRNA in homozygous Del2 (top panel) and
Ins4 (bottom panel) adult brain. Data were normalised to ATPsynth, NADH and 16S and were presented as means +− S.E.M.; n=3.
© 2020 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
License 4.0 (CC BY).
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zebrafish Eef1a1a and Eef1a1b are co-orthologues of mammalian eEF1A1. While Eef1a1l1 appears to lack a mam-
malian orthologue, the data also give strong support to zebrafish Eef1a2 being the sole orthologue of mammalian
genes encoding eEF1A2.
We have also demonstrated that all four zebrafish eef1a genes are actively transcribed and are expressed in a
development-specific pattern, consistent with the pattern seen in other vertebrates. During embryogenesis, eef1a1l1
is the only gene shown to have maternal contribution in addition to zygotic expression as it was detected at all em-
bryonic stages analysed. Interestingly, eef1a1l1 (formerly referred to as eef1a) has been shown to be an essential gene
required for early embryonic development in zebrafish [30]. In this study, mutation in eef1a1l1 was shown to result
in abnormal phenotypes such as small head and eyes from 2 dpf and eventually death at 5 dpf from failure of the
swim bladder to inflate. We found that the next eef1a genes to be detected were eef1a1a and eef1a1b, while eef1a2
was the last to be expressed, at 48 hpf. The detection of eef1a2 at a later developmental stage is consistent with that of
mammals, where its expression is observedmuch later in development than eEF1A1, gradually replacing it in skeletal
muscle and neurons [11,13,14].
In all adult tissues analysed, we detected mRNA derived from the eef1a1l1, eef1a1a and eef1a1b genes. On the
other hand, eef1a2 showed a tissue-specific expression pattern as its mRNA was not present in the liver and was
only just detected in the intestine, again similar to the expression seen in mammals. The difference between zebrafish
eef1a2 and the mammalian and Xenopus eEF1A2 orthologues however, is the presence of zebrafish eef1a2 mRNA
in spleen and ovary tissue samples. While the expression pattern of eef1a1a and eef1a1b is in contrast with that of
their mammalian orthologues, it is consistent with that of Xenopus where eEF1A1 mRNA, in addition to eEF1A2,
was detected in adult muscle [9]. Despite the eef1a genes being co-expressed in the tissues, quantification of their
expression levels in the brain, muscle and liver suggests that they are not present in equal amounts. As a whole,
eef1a1l1 transcripts are the most abundant, in muscle and liver compared with the other eef1a genes, while the levels
of all the eef1amRNA species were the same in the brain. The eef1a2 transcript was the secondmost abundant in the
muscle. In line with being co-paralogues, eef1a1a and eef1a1b exhibited the same expression pattern in these tissues.
The finding that the zebrafish eef1a genes display distinct expression profiles suggest they may have evolved unique
roles hence their being retained after the duplication events.
We were unable to establish specific expression patterns for zebrafish eef1a genes at the protein level as all com-
mercially available eEF1A antibodies we tested failed to distinguish between the products of the different zebrafish
eef1a genes. We were, however, able to see strong expression of eef1a2 specifically in brain.
We went on to generate two eef1a2 mutant lines, Ins4 and Del2, using CRISPR/Cas9 genome editing. Our qPCR
data showed a substantial decrease in eef1a2 expression in each of the two mutant lines with either of two sets of
primers. This finding indicates that the mutant transcripts are likely targets of nonsense-mediated decay, suggesting
that both the Ins4 and Del2 mutations are effectively null, since any remaining transcript would not encode a func-
tional protein. Homozygous loss of eef1a2 was not lethal in either of our zebrafish mutant lines, in contrast with the
situation in mice, which die before 4 weeks in the absence of eEF1A2. Adult homozygous Ins4 and Del2 mutants
showed no obvious phenotypic abnormalities, were fertile and produced viable embryos. There are three immediate
possible explanations for this discrepancy. Firstly the regenerative capacity of the zebrafish central nervous system
could be masking any neurodegeneration. Secondly, it remains possible the Ins4 and Del2 mutants retain some de-
gree of residual function of eef1a2. However, the consistency of the eef1a2 reduction observed with three different
set of primers at different locations from the target site makes this explanation unlikely, and any protein produced
from the residual transcripts would be so truncated that they would be highly unlikely to be functional. The third
explanation, which seems most likely, is that there is functional redundancy as a result of the three additional eef1a
genes which were found to be co-expressed with eef1a2 at the mRNA level. During the course of this work, Cao et al.
[28] reported that knockdown of eef1a2 with morpholinos resulted in abnormal phenotypes including small head
size, cardiac failure and skeletal muscle weakness in 2 dpf morphants. Since the development of efficient genome
editing techniques in zebrafish it has been increasingly recognised that CRISPR-induced mutants can fail to repli-
cate morpholino-induced phenotypes [2]. Cao et al. [28] did not investigate whether other eef1a gene(s) had been
down-regulated by the morpholinos used, and it is thus likely that the phenotypes observed were not specific to
eef1a2 but rather the combined effect of the knockdown of one or more of the other eef1a genes. Interestingly, a
small head, which was one of the phenotypes observed in the eef1a2morphants, was also reported in 2 dpf eef1a1l1
mutant recovered from a large retroviral-mediated insertional mutagenesis screen [30]. Although the phenotypes
observed were consistent between different types of morpholinos, translational and splice-site targeting, it is still pos-
sible that theymay have been the result of a common off-target toxic effect induced by bothmorpholinos. This type of
situation has been demonstrated in the study by Robu et al. [40], who observed that these two different types of mor-
pholinos induced off-target effects mediated through p53 activation in the zebrafish embryo. Furthermore, Kok et al.
12 © 2020 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution
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[2] showed that manymorpholino-induced phenotypes in zebrafish, even those that could be rescued by co-injecting
with the wild-type mRNA, were likely due to off-target effects and that off-target phenotypes induced by the use of
morpholinos occurredmuchmore frequently thanwas previously thought [2]. The discrepancy between our findings
and those of Cao et al. [28] might be due to the different approaches used which in turn induced different responses
to eef1a2 inactivation in zebrafish. Rossi et al. [3] demonstrated that genetically induced severe mutations resulted in
compensatory upregulation of specific proteins which rescued the phenotypes observed. However, our qPCR results
show that no up-regulation of any of the other eef1a genes occur at the mRNA level. Again, this is consistent with
the idea of functional redundancy of eef1a genes as the most likely explanation for the lack of abnormalities after the
loss of eef1a2 in Ins4 and Del2 mutant lines. In contrast with morpholinos, CRISPR/Cas9 has been shown to have
negligible off-target effects in zebrafish. Using next-generation sequencing (NGS), Hruscha et al. [41] demonstrated
that off-target effects were limited in founder fish. This study was small but was supported by another larger study
[42] in which the target sites for five gRNAs targeted to different genes were analysed. One 3 base pair deletion was
found, in only one of the 25 off-target loci tested [42]. The possibility of random off-target events occurring in the
Ins4 andDel2 lines cannot be ruled out, but, the use of mutant fish starting from the F2 generation and resulting from
an outcross of the F0 fish with wild-type fish should minimise the risks as off-target mutations should segregate away
from the Del2 and Ins4 eef1a2 mutation [43]. Furthermore, the comparison of two independent mutations and the
lack of any observable abnormalities suggest that off-target effects are not a concern.
Overall, our results suggest that ablating the expression of eEF1A2 in zebrafish is unlikely to provide a model
system to study disease-causing loss-of-function mutations. However, if the epilepsy-causing missense mutations
seen in humans in fact represent a toxic gain of function, our new Del2 and Ins4 lines could provide an important
resource in which to test the effects of expression of mutant eEF1A2 in the form of human mRNA.
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